Epithelial secretion of vinblastine by human intestinal adenocarcinoma cell (HCT-8 and T84) layers expressing P-glycoprotein
- PMID: 1680366
- PMCID: PMC1977668
- DOI: 10.1038/bjc.1991.328
Epithelial secretion of vinblastine by human intestinal adenocarcinoma cell (HCT-8 and T84) layers expressing P-glycoprotein
Abstract
P-glycoprotein expression was demonstrated in two human intestinal adenocarcinoma cell-lines (HCT-8, ileocaecal and T84, colonic) by immunoprecipitation of a 170-180 kDa protein with monoclonal antibody JSB-1. Both HCT-8 and T84 formed functional epithelial cell layers of high transepithelial electrical resistance (greater than 700 omega.cm2) when grown on permeable matrices. These epithelial layers demonstrated vectorial secretion (net vinblastine fluxes in the basal-to-apical direction of 0.135 and 0.452 pmol h-1 cm-2 in HCT-8 and T84 cell layers, respectively, from bathing solutions containing 10 nM vinblastine). These vectorial vinblastine secretions were sensitive to inhibition by verapamil. Passive transepithelial vinblastine permeation was limited by the presence of intercellular (tight) junctions, as demonstrated by the high transepithelial electrical resistance, and verapamil increased this passive vinblastine permeation concomitant with a reduction in the electrical resistance. Cellular vinblastine loading was significantly greater from the basal side, and this was also susceptible to inhibition by basal verapamil. The demonstration of vectorial transport of vinblastine in human intestinal colonic adenocarcinoma cell layers is direct evidence in favour of the hypothesis that the function of mdr1 in epithelial from the gastrointestinal tract is to promote detoxification by a process of epithelial secretion. This study also highlights that cellular vinblastine accumulation depends not only upon P-glycoprotein function, but also upon differential apparent membrane permeabilities and the presence of intercellular (tight) junctions that may restrict drug permeation and cellular accumulation to apical or basal membrane domains.
Similar articles
-
Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.Cancer Chemother Pharmacol. 1994;34(2):125-32. doi: 10.1007/BF00685929. Cancer Chemother Pharmacol. 1994. PMID: 7910786
-
Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators.J Biol Chem. 1993 Jul 15;268(20):14991-7. J Biol Chem. 1993. PMID: 8100817
-
Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia.J Biol Chem. 1989 Sep 5;264(25):14880-4. J Biol Chem. 1989. PMID: 2570070
-
Transepithelial secretion, cellular accumulation and cytotoxicity of vinblastine in defined MDCK cell strains.Biochim Biophys Acta. 1993 Oct 7;1179(1):1-10. doi: 10.1016/0167-4889(93)90069-2. Biochim Biophys Acta. 1993. PMID: 8104485
-
Mathematical models for multidrug resistance and its reversal.Cytotechnology. 1993;12(1-3):315-24. doi: 10.1007/BF00744670. Cytotechnology. 1993. PMID: 7765330 Review.
Cited by
-
pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions.Pharm Res. 2003 Aug;20(8):1141-8. doi: 10.1023/a:1025032511040. Pharm Res. 2003. PMID: 12948010
-
Carrier-mediated intestinal transport of drugs.Pharm Res. 1996 Jul;13(7):963-77. doi: 10.1023/a:1016086003070. Pharm Res. 1996. PMID: 8842032 Review.
-
Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers.Pharm Res. 1993 May;10(5):743-9. doi: 10.1023/a:1018972102702. Pharm Res. 1993. PMID: 8100632
-
Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS).Pharm Res. 1999 Oct;16(10):1550-6. doi: 10.1023/a:1015000503629. Pharm Res. 1999. PMID: 10554096
-
Overcome Drug Resistance in Cholangiocarcinoma: New Insight Into Mechanisms and Refining the Preclinical Experiment Models.Front Oncol. 2022 Mar 17;12:850732. doi: 10.3389/fonc.2022.850732. eCollection 2022. Front Oncol. 2022. PMID: 35372014 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources